Skip to main content
OpenTrials

Clinical trial condition

Renal Tubular Transport, Inborn Errors

Explore clinical trials studying Renal Tubular Transport, Inborn Errors. Study availability and eligibility vary by location and protocol.

92 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Renal Tubular Transport, Inborn Errors trial results

Completed

Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)

NCT02312687

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • University California San Francisco Hospital San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Indiana University Hospital Indianapolis, Indiana, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Completed

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

NCT02163577

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Indiana University Hospital Indianapolis, Indiana, United States
  • Shriners Hospital for Children St Louis, Missouri, United States
View Trial Details
Completed

Registry of Thiola EC Therapy

NCT05048563

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystinuria, Female Urogenital Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • NYU Langone Health New York, United States
  • Duke University Durham, North Carolina, United States
  • University of Texas Southwestern Dallas, Texas, United States
View Trial Details

Related conditions